Menu

Nanobiotix S.A. NBTX

Full chart Compare
Set alert

Price alert · NBTX

All alert types
30.63 USD +0.61 (+2.03%)

At closeNov 6, 2026, 4:00 PM EST

30.63 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

29.16 Day range 30.83
19.67 52-week range 55.07
YTD
+32.48%
1 year
+55.72%

Revenue & Expenses

Other Income → Expenses: $2.09MOther Operating Income → Expenses: $64.00KExpenses → Selling, General & Admin: $20.36MExpenses → Research & Development: $23.11MExpenses → Interest Expense: $15.23MGross Profit → Expenses: $32.59MRevenue → Gross Profit: $32.59MNet Loss → Expenses: $23.96MOther Income$2.09MOther Operating Income$64.00KGross Profit$32.59MNet Loss$23.96MExpenses$58.71MSelling, General & Admin$20.36MResearch & Development$23.11MInterest Expense$15.23MRevenue$32.59M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NBTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
32.59M-7.19M36.21M4.78M2.65M
32.59M-7.19M36.21M4.78M2.65M
-10.82M-68.39M-26.78M-46.70M-52.58M
-23.96M-68.13M-39.70M-57.04M-47.00M
-0.50-1.44-1.08-1.64-1.35
NBTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
52.75M49.74M75.28M41.39M83.92M
67.76M67.42M93.90M59.77M101.77M
152.24M133.12M95.74M86.81M74.98M
95.32M50.90M50.56M53.17M46.02M
-84.48M-65.70M-1.84M-27.05M26.79M
NBTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-33.42M-19.55M-12.48M-37.10M-29.87M
-578.00K-955.00K-349.00K138.00K-242.00K
37.42M-5.13M46.77M-5.65M-5.18M
-546.00K-848.00K-337.00K-93.00K-233.00K
3.01M-25.55M33.90M-42.53M-35.23M